TOSHIYUKI SHIBATA: Open Payments
NPI 1851396881 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 8 payments from 5 companies in 2025. Trend: 2023 $404 · 2024 $261 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $152 |
| Alkermes, Inc. | 3 | $78 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: ABILIFY MAINTENA, ARISTADA, LYBALVI, ABILIFY ASIMTUFII, COBENFY, UZEDY, FANAPT.
Industry payments across HI — which companies pay providers there.
